Drug Profile
IZN 6N4
Alternative Names: IZN6N4Latest Information Update: 28 Aug 2019
Price :
$50
*
At a glance
- Originator Izun Pharma
- Class Anti-inflammatories; Herbal medicines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Stomatitis
Most Recent Events
- 28 Aug 2019 IZN 6N4 is still in phase II trials for Stomatitis (Prevention) in USA and Israel (Izun Pharmaceuticals website, August 2019)
- 11 Oct 2017 Positive efficacy data from a phase II trial in Stomatitis released by Izun Pharma
- 11 Oct 2017 Izun Pharma completes a phase II trial in Stomatitis (Prevention) in USA and Israel (NCT01400620)